tiprankstipranks
pc:epige

Epigenic Therapeutics

Epigenic Therapeutics is a pioneering biotechnology company focused on developing next-generation gene modulation therapies through the regulation of the epigenetic genome. Utilizing its proprietary EPIREG(TM) technology platform, Epigenic offers innovative therapeutic solutions that provide efficient, durable, and specific gene silencing without the safety concerns associated with traditional gene-editing tools. The company is advancing a diverse pipeline of product candidates targeting metabolic, cardiovascular, viral hepatitis, ocular, and autoimmune diseases, leveraging its EpiTax(TM) delivery platform and AIAID(TM) platform for precise epigenetic modulation.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$60M
Total Amount Raised$60M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$60M
Latest Funding Amount$60M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 08, 2025
Series B
$60.00M

Investors

Investor Name
Funding Round
Series B
Series B

Related News and Analysis